Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING

VIA Disc NP Registry 3.0

NCT06345690 · View on ClinicalTrials.gov ↗

Study Summary

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

Interventions

  • OTHER VIA Disc NP

Study Locations (20)

Colorado

  • MD Pain — Englewood
  • Western Rockies Interventional Pain — Grand Junction
  • The Denver Spine & Pain Institute — Greenwood Village
  • Premier Spine and Pain Institute — Thornton

North Carolina

  • Premier Pain Solutions — Asheville
  • Comprehensive Pain Consultants of the Carolinas — Hendersonville
  • Crystal Coast Pain Management — Morehead City
  • Crystal Coast Pain Management — New Bern

Florida

  • The Orthopedic Institute — Gainesville
  • Raso Pain Center — Jupiter
  • Interventional Spine Care of the Palm Beaches — West Palm Beach

Louisiana

  • Interventional Pain Specialists - Pain Clinic — Opelousas
  • Paradigm Health System — Slidell

South Carolina

  • Atlantic Coast Spine & Pain — Conway
  • Renew Pain Solutions — Greenville

Arkansas

  • Mocek Spine — Little Rock

Georgia

  • Horizon Clinical Research — Jasper

Indiana

  • The Orthopedic Research Foundation, Inc. — Fishers

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-02-27
Est. Completion 2027-01-01

Sponsor

VIVEX Biologics

4 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06345690

The ClinicalTrials.gov registry entry for NCT06345690 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VIVEX Biologics, which has 4 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 3 conditions, with Back Pain appearing as the primary indexed condition, and to 1 intervention — of which VIA Disc NP is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT06345690 reports 20 study locations spanning 10 distinct geographic areas — top geographies include Colorado, North Carolina, Florida. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT06345690 about?

NCT06345690 is a clinical study titled "VIA Disc NP Registry 3.0". Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

What is the current status of trial NCT06345690?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-02-27. Estimated completion is 2027-01-01.

What conditions does trial NCT06345690 study?

This clinical trial studies the following conditions: Back Pain, Back Pain, Low, Discogenic Pain. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT06345690?

The interventions under investigation include: VIA Disc NP (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT06345690?

This trial is sponsored by VIVEX Biologics, which has 4 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT06345690 being conducted?

This trial has 20 study locations across Arkansas, Colorado, Florida, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial